INTREPId (INTermediate Risk Erection PreservatIon Trial)
INTREPId (INTermediate Risk Erection PreservatIon Trial)
Active, not recruiting · NCT04025372 · Registry updated 2025-12-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| INTREPId (INTermediate Risk Erection PreservatIon Trial) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 2 | 2025-12-15 | NCT04025372 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
| Brigham and Women's Hospital | 378 |
| Decipher Biosciences | 2 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Associated Medical Professionals of NY | Syracuse | United States | 8 |
| Beth Israel Deaconness Medical Center | Boston | United States | 1 |
| Brigham and Women Hospital | Boston | United States | 4 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center | Milford | United States | 4 |
| Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital | South Weymouth | United States | 3 |
| NYU Langone Health | New York | United States | 403 |
| NYU Long Island | Garden City | United States | 1 |
| Stamford Hospital | Stamford | United States | 10 |
| Washington University School of Medicine in St. Louis | St Louis | United States | 2 |
| XCancer Omaha / Urology Cancer Center | Omaha | United States | 7 |